| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
1795 |
| issn |
1179-1950
0012-6667 |
| issueIdentifier |
13 |
| pageRange |
1771-1795 |
| publicationName |
Drugs |
| startingPage |
1771 |
| bibliographicCitation |
McCormack PL, Keam SJ. Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Drugs. 2011 Sep 10;71(13):1771–95. doi: 10.2165/11207580-000000000-00000. PMID: 21902298. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c78686693fc90fab1b1c81303fe45d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc0e06065e4759c82d34256cb6361fd4 |
| date |
2011-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/21902298
https://doi.org/10.2165/11207580-000000000-00000 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0012-6667
https://portal.issn.org/resource/ISSN/1179-1950
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3453 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Dasatinib: a review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia |
| discusses |
http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0470497
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0457532 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7055
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9729
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043 |